Completed NA INTERVENTIONAL NCT00431548
Retinal Oxygen Reactivity in Patients Infected With Human Immunodeficiency Virus (HIV)
Retinal Oxygen Reactivity in Patients Infected With Human Immunodeficiency Virus (HIV).
Sponsor: Medical University of Vienna
Conditions
HIV Infections Ocular Physiology Retina
Interventions
100% O2
Updated 4 times since 2017 Last updated: Feb 5, 2007
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on HIV Infections and Ocular Physiology, this trial is completed. The trial is conducted by Medical University of Vienna and has accumulated 4 data snapshots since 2026. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jan 2017 — Jan 2021 [monthly]
Completed NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Medical University of Vienna
Data source: Medical University of Vienna
For direct contact, visit the study record on ClinicalTrials.gov .